LGC Biosearch Technologies

Petaluma, CA · Middleton, WI

Oligonucleotide

Program data pending ClinicalTrials.gov matching · Last scored 2026-04-29

63.0

Signal Score

○ FDA Inspections ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: LGC Biosearch Technologies

Signal Score: 63.0/100 (as of 2026-04-29)
Quality Compliance: Assessment pending
Headquarters: Petaluma, CA · Middleton, WI
Modalities: Oligonucleotide
Active Programs: No ClinicalTrials.gov matches confirmed
Data Sources: FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By: CDMO Signal — independent CDMO intelligence platform

Pure-play CDMO.

Quality Compliance —

No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.

FDA InspectionsNo US records on file

No FDA inspection records found for this manufacturer

Quality score requires FDA inspection data

Operations —

No ClinicalTrials.gov facility matches confirmed for this manufacturer.

Programs — no verified data

Sponsors— no verified data

ModalitiesOligonucleotide

No clinical trial matches found for this manufacturer

Operational score requires ClinicalTrials.gov data

Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.

Financial Stability

Profile-based financial assessment

SEC FilingsPrivate company

Parent company: LGC Group

Financial assessment: 68.0/100

Capacity

2 manufacturing sites

Minor (2) Other 2025-08-20 21 CFR 801.40(a)

Form of a unique device identifier

"The medical device(s) label did not have a unique device identifier (UDI) present in easily readable plain-text and automatic identification and data capture (AIDC) technology."
Minor (2) Documentation & Records 2025-08-20 21 CFR 820.198(a)

Lack of or inadequate complaint procedures

"Procedures for receiving, reviewing, and evaluating complaints by a formally designated unit have not been adequately established."
Minor (2) Documentation & Records 2025-08-20 21 CFR 820.80(d)

Lack of or inadequate final acceptance procedures

"Procedures for finished device acceptance have not been adequately established."